Mosaic Biosciences
Accelerating the development of protein therapeutics
Accelerating the development of protein therapeutics
Mosaic Biosciences is a biotechnology startup founded in 2009 in the United States. The company's slogan "Accelerating the development of protein therapeutics" aligns with its core mission of transforming concepts into drug candidates with end-to-end discovery capabilities. With a first-class multidisciplinary team, Mosaic Biosciences offers experienced biopharma leadership and cross-functional teams to accelerate protein therapeutic research and development programs. Notably, the company recently secured a significant $11.40MVenture Round investment on 14 June 2022, with participation from Telegraph Hill Partners and Dan Mitchell. This injection of funds underscores confidence in Mosaic Biosciences' innovative approach and potential for growth in the biotechnology sector.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $11.40M | 2 |
|
14 Jun 2022 |
| Venture Round | $2.27M | - | 10 Feb 2014 | |
| Series A | $1.00M | 3 |
|
08 Nov 2011 |
No recent news or press coverage available for Mosaic Biosciences.
We care about your data, and we'd love to use cookies make your experience better.
